General Practitioners Research Institute (GPRI)
This sponsor has funded 2 studies across 1 countries.
| EU PAS ID | Status | RMP requirement | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|---|
| 27806 | Ongoing | Not included in RMP | Prevalence of COPD patients with signs of asthma according to Dutch GP guidelines | No | No |
| 36118 | Ongoing | Not included in RMP | Description of the pharmaceutical treatment advice in patients with respiratory symptoms in primary care setting (DEPART) | No | No |
PAS by Risk Management Plan (RMP) requirement
General Practitioners Research Institute (GPRI)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
General Practitioners Research Institute (GPRI)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
General Practitioners Research Institute (GPRI)
1 Study countries specified are the following:
- Netherlands